Reinier Beeuwkes

Dr. Beeuwkes joined Ischemix in 2002 as a Director and was appointed President/CEO in 2005. Dr. Beeuwkes began his career working with Nobelist Bernard Lown on "cardioversion", the electrical correction of cardiac arrhythmia. From 1970 to 1982, Dr. Beeuwkes held a faculty position at Harvard Medical School. His work centered on the microcirculation of the kidney and heart, and resulted in more than 80 publications, including four chapters in renal textbooks and three award-winning kidney-focused educational films. With A. Clifford Barger, he discovered the association of coronary vasa vasorum with atherosclerotic plaque. This work is widely cited in myocardial infarction literature. In 1982, Dr. Beeuwkes co-founded Braintree Laboratories, Inc., a privately held pharmaceutical company which pioneered products for colonoscopy. From 1982-1987, he served as Director of Renal and Cardiovascular Pharmacology at Smith Kline and French Laboratories and Director of Strategic Planning for SmithKline Worldwide R&D. He holds nine U.S. patents. Dr. Beeuwkes earned his B.S. from The Massachusetts Institute of Technology and his Ph.D. from Harvard University.